BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18072858)

  • 1. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
    Foust KD; Flotte TR; Reier PJ; Mandel RJ
    Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-spinal cord injury astrocyte-mediated functional recovery in rats after intraspinal injection of the recombinant adenoviral vectors Ad5-VEGF and Ad5-ANG.
    Povysheva T; Shmarov M; Logunov D; Naroditsky B; Shulman I; Ogurcov S; Kolesnikov P; Islamov R; Chelyshev Y
    J Neurosurg Spine; 2017 Jul; 27(1):105-115. PubMed ID: 28452633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dendritic morphology and neurotransmitter phenotype of thoracic descending propriospinal neurons after complete spinal cord transection and GDNF treatment.
    Deng L; Ruan Y; Chen C; Frye CC; Xiong W; Jin X; Jones K; Sengelaub D; Xu XM
    Exp Neurol; 2016 Mar; 277():103-114. PubMed ID: 26730519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector.
    Hutson TH; Verhaagen J; Yáñez-Muñoz RJ; Moon LD
    Gene Ther; 2012 Jan; 19(1):49-60. PubMed ID: 21562590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced neuroprotection and improved motor function in traumatized rat spinal cords by rAAV2-mediated glial-derived neurotrophic factor combined with early rehabilitation training.
    Han Q; Xiang J; Zhang Y; Qiao H; Shen Y; Zhang C
    Chin Med J (Engl); 2014; 127(24):4220-5. PubMed ID: 25533825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
    Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
    Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.
    Islamov RR; Rizvanov AA; Mukhamedyarov MA; Salafutdinov II; Garanina EE; Fedotova VY; Solovyeva VV; Mukhamedshina YO; Safiullov ZZ; Izmailov AA; Guseva DS; Zefirov AL; Kiyasov AP; Palotas A
    Curr Gene Ther; 2015; 15(3):266-76. PubMed ID: 25619885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral vector carrying glial cell-derived neurotrophic factor for direct gene therapy in comparison with human umbilical cord blood cell-mediated therapy of spinal cord injury in rat.
    Mukhamedshina YO; Shaymardanova GF; Garanina ЕЕ; Salafutdinov II; Rizvanov АА; Islamov RR; Chelyshev YA
    Spinal Cord; 2016 May; 54(5):347-59. PubMed ID: 26415641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
    Suzuki M; Svendsen CN
    Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
    Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
    Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor Cortex Activity Organizes the Developing Rubrospinal System.
    Williams PT; Martin JH
    J Neurosci; 2015 Sep; 35(39):13363-74. PubMed ID: 26424884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
    Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration.
    Liu Y; Keefe K; Tang X; Lin S; Smith GM
    PLoS One; 2014; 9(2):e87447. PubMed ID: 24498323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of direct and cell-mediated triple-gene therapy in spinal cord injury in rats.
    Islamov RR; Izmailov AA; Sokolov ME; Fadeev PO; Bashirov FV; Eremeev AA; Shaymardanova GF; Shmarov MM; Naroditskiy BS; Chelyshev YA; Lavrov IA; Palotás A
    Brain Res Bull; 2017 Jun; 132():44-52. PubMed ID: 28529158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis.
    Thomsen GM; Avalos P; Ma AA; Alkaslasi M; Cho N; Wyss L; Vit JP; Godoy M; Suezaki P; Shelest O; Bankiewicz KS; Svendsen CN
    Stem Cells; 2018 Jul; 36(7):1122-1131. PubMed ID: 29656478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of Danshen injection on glial cell line-derived neurotrophic factor mRNA of acute spinal cord injury rats and its mechanisms].
    Wei L; Zhang L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jul; 33(7):933-7. PubMed ID: 24063216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial.
    Baloh RH; Johnson JP; Avalos P; Allred P; Svendsen S; Gowing G; Roxas K; Wu A; Donahue B; Osborne S; Lawless G; Shelley B; Wheeler K; Prina C; Fine D; Kendra-Romito T; Stokes H; Manoukian V; Muthukumaran A; Garcia L; Bañuelos MG; Godoy M; Bresee C; Yu H; Drazin D; Ross L; Naruse R; Babu H; Macklin EA; Vo A; Elsayegh A; Tourtellotte W; Maya M; Burford M; Diaz F; Patil CG; Lewis RA; Svendsen CN
    Nat Med; 2022 Sep; 28(9):1813-1822. PubMed ID: 36064599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Injection of a Lentiviral Vector Highlights Multiple Motor Pathways in the Rat Spinal Cord.
    Keefe KM; Junker IP; Sheikh IS; Campion TJ; Smith GM
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30933070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.